09955243 · Active · incorporated 10 years, 6 months ago · Saffron Walden
Biotech Biotech & Life Sciences Drug Discovery Series B+
Develops gSynth®, a TdT-free enzymatic DNA synthesis technology for high-throughput production of synthetic genes.
See the complete cap table with every shareholder, founder tags, dilution across 26 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.